Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy

by Deirdre Kelly, Anna Spreafico, Marcus O Butler, David Hogg, Danny Ghazarian, April A N Rose, Thiago Pimentel Muniz, Samuel D Saibil, Susan M Armstrong, Diana P Arteaga, Ian King, Zaid Saeed Kamil, Kendra Ross
Published 2021-01-01

Acute graft-versus-host disease after double lung transplantation

by Nicole Kim, MD, Nadia Kashetsky, MSc, Yuliya Velykoredko, MD, FRCPC, Michelle Murray, MD, MRCPI, MSc, Lianne Singer, MD, FRCPC, Zaid Saeed Kamil, MBChB, FRCPC, Danny Ghazarian, MD, ChB, PhD, FRCPC, An-Wen Chan, MD, DPhil, FRCPC
Published 2021-07-01

Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors

by Deirdre Kelly, April A. N. Rose, Thiago Pimentel Muniz, David Hogg, Marcus O. Butler, Samuel D. Saibil, Ian King, Zaid Saeed Kamil, Danny Ghazarian, Kendra Ross, Marco Iafolla, Daniel V. Araujo, John Waldron, Normand Laperriere, Hatem Krema, Anna Spreafico
Published 2021-07-01